Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 27:10:455-63.
doi: 10.2147/DDDT.S98466. eCollection 2016.

Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2

Affiliations

Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2

Weitao Fu et al. Drug Des Devel Ther. .

Abstract

It is recognized that myeloid differentiation protein 2 (MD-2), a coreceptor of toll-like receptor 4 (TLR4) for innate immunity, plays an essential role in activation of the lipopolysaccharide signaling pathway. MD-2 is known as a neoteric and suitable therapeutical target. Therefore, there is great interest in the development of a potent MD-2 inhibitor for anti-inflammatory therapeutics. Several studies have reported that xanthohumol (XN), an anti-inflammatory natural product from hops and beer, can block the TLR4 signaling by binding to MD-2 directly. However, the interaction between MD-2 and XN remains unknown. Herein, our work aims at characterizing interactions between MD-2 and XN. Using a combination of experimental and theoretical modeling analysis, we found that XN can embed into the hydrophobic pocket of MD-2 and form two stable hydrogen bonds with residues ARG-90 and TYR-102 of MD-2. Moreover, we confirmed that ARG-90 and TYR-102 were two necessary residues during the recognition process of XN binding to MD-2. Results from this study identified the atomic interactions between the MD-2 and XN, which will contribute to future structural design of novel MD-2-targeting molecules for the treatment of inflammatory diseases.

Keywords: binding mode; inflammation; molecular dynamics simulation; myeloid differentiation 2; xanthohumol.

PubMed Disclaimer

Figures

Figure 1
Figure 1
XN’s binding activity to MD-2 protein. Notes: (A) The structure of XN. (B) SPR shows direct interactions between XN and the wild type of MD-2 protein. (C) ELISA assay showing XN inhibition of biotin-LPS binding to wild-type MD-2 protein. Data are mean values (± SEM) of at least three separate repeated experiments (**P<0.01). Abbreviations: ELISA, enzyme-linked immunosorbent assay; LPS, lipopolysaccharide; MD-2, myeloid differentiation protein 2; SEM, standard error of the mean; SPR, surface plasmon resonance; XN, xanthohumol; Ka, association (‘on rate’); Kd, dissociation rates (‘off rate’); KD, equilibrium dissociation constant (‘binding constant’); WT, wild type.
Figure 2
Figure 2
Molecular docking analysis of XN to the activity cavity of MD-2. Notes: (A) XN overlapped with LPS in the binding site of MD-2 together with TLR4. TLR4 (cyan), MD-2 (wheat), LPS (green sticks), XN (blue spheres). (B) Overlapped region of XN (blue sticks) and LPS (green sticks). (C) Molecular docking analysis of three-dimensional binding pose between XN and MD-2. MD-2 (wheat cartoon), XN (cyan sticks), hydrogen bonds (black dotted lines). Abbreviations: LPS, lipopolysaccharide; MD-2, myeloid differentiation protein 2; TLR4, toll-like receptor 4; XN, xanthohumol.
Figure 3
Figure 3
Backbone RMSDs are shown as a function of time for apo MD-2 and XN/MD-2 complex structures at 50 ns. Notes: (A) Time evolution of the RMSD of MD-2 and XN are shown with black lines and red lines, respectively. (B) The time evolution of the RMSD of apo MD-2. (C) The XN/MD-2 complex system. The alignments of starting (wheat) and final (blue) structures. (D) Apo MD-2 system. The alignments of starting (wheat) and final (blue) structures. Abbreviations: MD-2, myeloid differentiation protein 2; RMSD, root-mean square deviation; XN, xanthohumol.
Figure 4
Figure 4
The “openness” of apo MD-2 and XN/MD-2 complex. Notes: (A) Total distance between center of mass of apo MD-2 and every center of mass of β strand. (B) Total distance between center of mass of XN/MD-2 complex and every center of mass of β strand. Abbreviations: MD-2, myeloid differentiation protein 2; XN, xanthohumol.
Figure 5
Figure 5
Key hydrogen interactions between XN and residues ARG-90 and TYR-102 of MD-2. Notes: (A) XN (yellow sticks), residues AGR-90 and TYR-102 (white sticks covered with transparent surface), hydrogen bonds (black dotted lines); hydrogen atoms are omitted. (B) The distance for the hydrogen bonds between XN and the residue TYR-102 as a function of time. (C) The distances for the hydrogen bonds between XN and residue ARG-90 as a function of time. Abbreviations: MD-2, myeloid differentiation protein 2; XN, xanthohumol.
Figure 6
Figure 6
XN shows low binding affinity to the MD-2R90A/Y102A mutant. Notes: (A) SPR assay indicating loss of high affinity binding of XN with the R90A and Y102A mutants of MD-2. (B) ELISA assay of XN competition with biotin-LPS binding to the MD-2R90A/Y102A mutant. Abbreviations: ELISA, enzyme-linked immunosorbent assay; LPS, lipopolysaccharide; MD-2, myeloid differentiation protein 2; SPR, surface plasmon resonance; XN, xanthohumol; Ka, association (‘on rate’); Kd, dissociation rates (‘off rate’); KD, equilibrium dissociation constant (‘binding constant’).

Similar articles

Cited by

References

    1. Hecht G. Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol. 1999;277(3 Pt 1):C351–C358. - PubMed
    1. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340(2):115–126. - PubMed
    1. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80–86. - PubMed
    1. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–949. - PubMed
    1. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453–461. - PubMed

Publication types

LinkOut - more resources